Evidence map›Paper›PMID 26881253›Full record

ArticleJournal of diabetes research2016

Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro.

Zhimei Lv, Mengsi Hu, Xiaoxu Ren, Minghua Fan, Junhui Zhen, Liqun Chen, Jiangong Lin, Nannan Ding, Qun Wang, Rong Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Podocytes in health and glomerular disease.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Enhanced Orai1-mediated store-operated CaThe Journal of biological chemistry · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Zhimei LvDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Mengsi HuDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Xiaoxu RenDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Minghua FanDepartment of Obstetrics and Gynecology, Second Hospital of Shandong University, Jinan 250033, China.
Junhui ZhenDepartment of Pathology, Medical School of Shandong University, Jinan 250012, China.
Liqun ChenDepartment of Nephrology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
Jiangong LinDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Nannan DingDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Qun WangDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Rong WangDepartment of Nephrology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.
Shandong University · CNShandong Provincial Hospital · CNFirst Affiliated Hospital of Chongqing Medical University · CNSecond Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fyn, a member of the Src family of tyrosine kinases, is a key regulator in cytoskeletal remodeling in a variety of cell types. Recent studies have demonstrated that Fyn is responsible for nephrin tyrosine phosphorylation, which will result in polymerization of actin filaments and podocyte damage. Thus detailed involvement of Fyn in podocytes is to be elucidated. In this study, we investigated the potential role of Fyn/ROCK signaling and its interactions with paxillin. Our results presented that high glucose led to filamentous actin (F-actin) rearrangement in podocytes, accompanied by paxillin phosphorylation and increased cell motility, during which Fyn and ROCK were markedly activated. Gene knockdown of Fyn by siRNA showed a reversal effect on high glucose-induced podocyte damage and ROCK activation; however, inhibition of ROCK had no significant effects on Fyn phosphorylation. These observations demonstrate that in vitro Fyn mediates high glucose-induced actin cytoskeleton remodeling of podocytes via promoting ROCK activation and paxillin phosphorylation.

Indexed as

Actin CytoskeletonActinsAnimalsBlood GlucoseCell MovementGlucoseMembrane ProteinsMicePaxillinPhosphorylationPodocytesProto-Oncogene Proteins c-fynrho-Associated KinasesRNA InterferenceRNA, Small InterferingSignal TransductionActinsBlood GlucoseFyn protein, mouseGlucoseMembrane ProteinsnephrinPaxillinProto-Oncogene Proteins c-fynrho-Associated KinasesRNA, Small Interfering

Identifiers

PMID26881253
PMCPMC4736797
OpenAlexW2224447222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.